Professor of Medicine, Harvard Medical School, Director, The Center for Clinical Investigation, Director, Research Program in Men's Health: Aging and Metabolism, Brigham and Women's Hospital, Boston, Massachusetts 02115.
J Clin Endocrinol Metab. 2016 Mar;101(3):827-36. doi: 10.1210/jc.2015-3843. Epub 2016 Feb 23.
Men's health and aging are emerging as important areas of research opportunity because of advances in reproductive biology and the recognition of men's health as a unique and important aspect of public health.
A perspective of the evolving landscape in male reproductive medicine.
Remarkable discoveries in reproductive biology have greatly advanced the treatment of erectile dysfunction, androgen deficiency, infertility, hormone sensitive cancers, and prostate diseases. Although the off-label use of testosterone in middle-aged and older men has grown, the management of androgen deficiency syndromes remains suboptimal. There is a pressing need for wider adoption of accurate testosterone assays and harmonized reference ranges and large randomized trials of testosterone's efficacy and cardiovascular and prostate safety. The transformation in idealized body image towards greater muscularity has contributed to increasing prevalence of body image disorders and the use of muscle building drugs in men. Therapeutic options for fertility regulation in men remain limited, the pathophysiologic basis of infertility in a vast majority of infertile men remains unknown, and assisted reproductive technologies remain inaccessible to many infertile men. Much of the dogma on testosterone's binding to its binding proteins remains inaccurate, and the role of free and albumin-bound testosterone poorly understood. The reproductive health of cancer survivors and the availability of wider contraceptive choices for men are other areas of unmet need. Suboptimal care of transgender persons has framed transgender medicine as an important healthcare disparities issue.
Transformative changes in societal attitudes towards men's sexual health, body image, and gender identity, and in the economics of reproductive healthcare services, offer extraordinary opportunities for translational science that is patient focused, mechanism based, and integrated with healthcare.
由于生殖生物学的进步以及认识到男性健康是公共卫生的一个独特而重要的方面,男性健康和衰老已成为研究的重要领域。
男性生殖医学不断发展的视角。
生殖生物学的显著发现极大地提高了勃起功能障碍、雄激素缺乏、不育、激素敏感癌症和前列腺疾病的治疗水平。尽管在中年和老年男性中使用睾酮的非适应证治疗有所增加,但雄激素缺乏综合征的管理仍不理想。迫切需要更广泛地采用准确的睾酮检测和协调的参考范围,并进行大规模的随机试验,以评估睾酮的疗效以及心血管和前列腺安全性。理想化的身体形象向更大的肌肉发达方向的转变导致了身体形象障碍和男性使用肌肉增强药物的流行率增加。男性生育调节的治疗选择仍然有限,绝大多数不育男性的不育病理生理学基础仍然未知,许多不育男性无法获得辅助生殖技术。关于睾酮与其结合蛋白结合的大部分教条仍然不准确,并且游离和白蛋白结合睾酮的作用知之甚少。癌症幸存者的生殖健康以及男性更广泛的避孕选择的可用性是其他未满足需求的领域。跨性别者护理的不足将跨性别医学定义为重要的医疗保健差异问题。
社会对男性性健康、身体形象和性别认同的态度以及生殖保健服务的经济学发生了变革性的变化,为以患者为中心、基于机制和与医疗保健相结合的转化科学提供了非凡的机会。